Further, the amount of H1R binding assessed by positron emission tomography was significantly reduced in the frontal and temporal areas of AD patients compared to controls, revealing a disruption of the histaminergic neurotransmission in AD pathology [96]. Here, HRH1 is linked to Alzheimer disease.